Innovations December 2024
The Second Berlin Patient
Fighting for Equality in Nepal
Two Diseases, One Response
Timing Is Everything
A View from the Top
amfAR CEO Kevin Robert Frost introduces the new issue of Innovations.
Lenacapavir Looks to Revolutionize HIV Prevention
PURPOSE 2 study results show that a twice-yearly injectable HIV antiretroviral, lenacapavir, is highly effective as PrEP among MSM, transgender women and men who have sex with men, and others.
amfAR CEO at White House Cancer Moonshot Meeting
At a White House Cancer Moonshot meeting, amfAR CEO Kevin Robert Frost shared how HIV funding strategies might work for global cancer initiatives.
AIDS at a Crossroads
New global update from UNAIDS highlights progress but warns countries need to stay on track to end AIDS.
Rising to the Occasion
Plaudits at the International AIDS Conference for amfAR’s Greg Millett and Annette Sohn, and for the RISE Study, co-sponsored by amfAR.
Women in the Asia-Pacific Region: A Neglected Population
amfAR’s TREAT Asia think tank participants highlight the clinical, research, and policy needs of women living with and at risk of HIV.
View Previous Issues
of INNOVATIONS Here.
